NCT06627998

Brief Summary

This is a multicenter retrospective observational study aimed to evaluate the prevalence of osteo-metabolic complications in patients with thyroid cancer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
82

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2023

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

October 3, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 4, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

October 4, 2024

Status Verified

October 1, 2024

Enrollment Period

1.6 years

First QC Date

October 3, 2024

Last Update Submit

October 3, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • To estimate the incidence and prevalence of osteoporosis and vertebral fractures in Patients With Thyroid Cancer

    To estimate the incidence and prevalence of osteoporosis and vertebral fractures detected through DXA scan and vertebral morphometry. The effects on bone complications of the patients' clinical and biochemical characteristics will be investigated.

    1 year

Interventions

Biochemical, clinical and radiological data performed for clinical practice will be retrospectively collected. Osteoporosis and vertebral fractures will be diagnosed through DXA scan and vertebral morphometry.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with thyroid cancers who have been evaluated at the outpatient clinics of the Endocrinology Unit of the IRCCS San Raffaele Hospital and the Nuclear Medicine Unit of the Spedali Civili di Brescia.

You may qualify if:

  • age ≥ 18 years
  • Histological diagnosis of Thyroid Carcinoma
  • radiological data from chest x-ray in lateral projection in the preoperative evaluation on which the vertebral morphometry
  • Signing of the informed consent

You may not qualify if:

  • Subjects not falling within the previously described criteria are excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Andrea Giustina

Milan, 20132, Italy

RECRUITING

MeSH Terms

Conditions

Thyroid NeoplasmsSpinal FracturesOsteoporosis

Interventions

DiagnosisDiagnostic Imaging

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid DiseasesSpinal InjuriesBack InjuriesWounds and InjuriesFractures, BoneBone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and Procedures

Central Study Contacts

Luigi Di Filippo, medical doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Endocrinology

Study Record Dates

First Submitted

October 3, 2024

First Posted

October 4, 2024

Study Start

April 12, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

October 4, 2024

Record last verified: 2024-10

Locations